Emma Rose Hinkle

Emma Rose Hinkle

Auto-generated profile, based on publicly available information

Emma Rose Hinkle

Department of Cell Biology and Physiology, The University of North Carolina at Chapel Hill, Chapel Hill, USA

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 October 2018 in Transcription
Verified
Journal Article
Closed access
EHEmma R Hinkle
Emma R Hinkle
HWHannah J Wiedner
Hannah J Wiedner
ABAdam J Black
Adam J Black
JGJimena Giudice
Jimena Giudice
RNA processing encompasses the capping, cleavage, polyadenylation and alternative splicing of pre-mRNA. Proper muscle development relies on precise RNA processing, driven by the coordination between RNA-binding proteins. Recently, skeletal muscle biology has been intensely investigated in terms of RNA processing. High throughput studies paired with deletion of RNA-binding proteins have provided a high-level understanding of the molecular mechanisms controlling the regulation of RNA-processing in skeletal muscle. Furthermore, misregulation of RNA processing is implicated in muscle diseases. In this review, we comprehensively summarize recent studies in skeletal muscle that demonstrated: (i) the importance of RNA processing, (ii) the RNA-binding proteins that are involved, and (iii) diseases associated with defects in RNA processing.

17 May 2019 in RNA
Verified
Journal Article
Open access
PDF file
MSMegan D. Schertzer
Megan D. Schertzer
ETEliza Thulson
Eliza Thulson
KBKeean C.A. Braceros
Keean C.A. Braceros
DLDavid M. Lee
David M. Lee
EHEmma R. Hinkle
Emma R. Hinkle
MCMauro Calabrese
Mauro Calabrese
We describe the development and application of a novel series of vectors that facilitate CRISPR-Cas9-mediated genome editing in mammalian cells, which we call CRISPR-Bac. CRISPR-Bac leverages the piggyBac transposon to randomly insert CRISPR-Cas9 components into mammalian genomes. In CRISPR-Bac, a single piggyBac cargo vector containing a doxycycline-inducible Cas9 or catalytically dead Cas9 (dCas9) variant and a gene conferring resistance to Hygromycin B is cotransfected with a plasmid expressing the piggyBac transposase. A second cargo vector, expressing a single-guide RNA (sgRNA) of interest, the reverse-tetracycline TransActivator (rtTA), and a gene conferring resistance to G418, is also cotransfected. Subsequent selection on Hygromycin B and G418 generates polyclonal cell populations that stably express Cas9, rtTA, and the sgRNA(s) of interest. We show that CRISPR-Bac can be used to knock down proteins of interest, to create targeted genetic deletions with high efficiency, and to activate or repress transcription of protein-coding genes and an imprinted long noncoding RNA. The ratio of sgRNA-to-Cas9-to-transposase can be adjusted in transfections to alter the average number of cargo insertions into the genome. sgRNAs targeting multiple genes can be inserted in a single transfection. CRISPR-Bac is a versatile platform for genome editing that simplifies the generation of mammalian cells that stably express the CRISPR-Cas9 machinery.

16 December 2021 in Skeletal Muscle
Verified
Journal Article
Open access
PDF file
EHEmma Rose Hinkle
Emma Rose Hinkle
TETasneem Omar Essader
Tasneem Omar Essader
GGGabrielle Gentile
Gabrielle Gentile
JGJimena Giudice
Jimena Giudice
Background: Measuring biological features of skeletal muscle cells is difficult because of their unique morphology and multinucleate nature upon differentiation. Here, we developed a new Fiji macro package called ViaFuse (that stands for viability and fusion) to measure skeletal muscle cell viability and differentiation. To test ViaFuse, we utilized immunofluorescence images of differentiated myotubes where the capping actin protein of muscle z-line subunit beta (CAPZB) was depleted in comparison with control cells. Results: We compared the values achieved using the ViaFuse macros first with manual quantification performed by researchers and second with those obtained utilizing the MATLAB muscle-centric software MyoCount. We observed a high degree of correlation between all methods of quantification. Conclusions: ViaFuse can detect the borders of myotubes and identify nuclear clumps which have been limitations of previous muscle-centric imaging software. The ViaFuse macros require little computer power or space to run and user inputs to the ViaFuse macros are minimal, thereby automating the analysis process in a quick, easy, and accurate fashion. Additionally, the ViaFuse macros work with Fiji, an existing imaging software widely used by skeletal muscle researchers. Furthermore, ViaFuse is compatible with many computer systems, has a very intuitive interface, and does not require prior complex mathematical knowledge. Therefore, we propose ViaFuse as a robust and meticulous method to quantify skeletal muscle cell viability and differentiation.
1

26 January 2022 in RNA
Verified
Journal Article
Open access
PDF file
EHEmma R. Hinkle
Emma R. Hinkle
HWHannah J. Wiedner
Hannah J. Wiedner
ETEduardo V. Torres
Eduardo V. Torres
MJMicaela Jackson
Micaela Jackson
ABAdam J. Black
Adam J. Black
JGJimena Giudice
Jimena Giudice
Alternative splicing transitions occur during organ development, and, in numerous diseases, splicing programs revert to fetal isoform expression. We previously found that extensive splicing changes occur during postnatal mouse heart development in genes encoding proteins involved in vesicle-mediated trafficking. However, the regulatory mechanisms of this splicing-trafficking network are unknown. Here, we found that membrane trafficking genes are alternatively spliced in a tissue-specific manner, with striated muscles exhibiting the highest levels of alternative exon inclusion. Treatment of differentiated muscle cells with chromatin-modifying drugs altered exon inclusion in muscle cells. Examination of several RNA-binding proteins revealed that the poly-pyrimidine tract binding protein 1 (PTBP1) and quaking regulate splicing of trafficking genes during myogenesis, and that removal of PTBP1 motifs prevented PTBP1 from binding its RNA target. These findings enhance our understanding of developmental splicing regulation of membrane trafficking proteins which might have implications for muscle disease pathogenesis.

19 September 2022 in Communications Biology
Verified
Journal Article
Open access
PDF file
EHEmma R. Hinkle
Emma R. Hinkle
RBR. Eric Blue
R. Eric Blue
YTYi-Hsuan Tsai
Yi-Hsuan Tsai
MCMatthew Combs
Matthew Combs
JDJacquelyn Davi
Jacquelyn Davi
JGJimena Giudice
Jimena Giudice
Alternative splicing is an RNA processing mechanism involved in skeletal muscle development and pathology. Muscular diseases exhibit splicing alterations and changes in mechanobiology leading us to investigate the interconnection between mechanical forces and RNA processing. We performed deep RNA-sequencing after stretching muscle cells. First, we uncovered transcriptional changes in genes encoding proteins involved in muscle function and transcription. Second, we observed that numerous mechanosensitive genes were part of the MAPK pathway which was activated in response to stretching. Third, we revealed that stretching skeletal muscle cells increased the proportion of alternatively spliced cassette exons and their inclusion. Fourth, we demonstrated that the serine and arginine-rich proteins exhibited stronger transcriptional changes than other RNA-binding proteins and that SRSF4 phosphorylation is mechanosensitive. Identifying SRSF4 as a mechanosensitive RNA-binding protein that might contribute to crosstalk between mechanotransduction, transcription, and splicing could potentially reveal novel insights into muscular diseases, particularly those with unknown etiologies.

10 October 2022 in Communications Biology
Verified
Journal Article
Open access
PDF file
EHEmma R. Hinkle
Emma R. Hinkle
RBR. Eric Blue
R. Eric Blue
YTYi-Hsuan Tsai
Yi-Hsuan Tsai
MCMatthew Combs
Matthew Combs
JDJacquelyn Davi
Jacquelyn Davi
JGJimena Giudice
Jimena Giudice